iShares Genomics Immunology and Healthcare ETF (IDNA)
NYSEARCA: IDNA · Real-Time Price · USD
28.52
+0.71 (2.54%)
Mar 31, 2026, 12:24 PM EDT - Market open
IDNA Holdings Information
IDNA is an equity ETF with a total of 66 individual holdings. The top holdings are Moderna stock at 6.75%, Arcellx at 5.48%, Takeda Pharmaceutical Company at 4.84%, Ipsen at 4.82%, and Merck & Co. at 4.52%.
Total Holdings
66
Top 10 Percentage
47.04%
Asset Class
Equity
ETF Category
Health
Assets
144.46M
PE Ratio
14.18
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 6.75% |
| 2 | ACLX | Arcellx, Inc. | 5.48% |
| 3 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 4.84% |
| 4 | EPA: IPN | Ipsen S.A. | 4.82% |
| 5 | MRK | Merck & Co., Inc. | 4.52% |
| 6 | RVMD | Revolution Medicines, Inc. | 4.38% |
| 7 | ETR: BAYN | Bayer Aktiengesellschaft | 4.28% |
| 8 | LON: GSK | GSK plc | 4.26% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | 3.87% |
| 10 | SWX: ROP | Roche Holding AG | 3.82% |
| 11 | EPA: SAN | Sanofi | 3.60% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 3.59% |
| 13 | EXEL | Exelixis, Inc. | 3.53% |
| 14 | BNTX | BioNTech SE | 3.36% |
| 15 | INCY | Incyte Corporation | 3.32% |
| 16 | CPH: GMAB | Genmab A/S | 3.09% |
| 17 | TWST | Twist Bioscience Corporation | 2.87% |
| 18 | IDYA | IDEAYA Biosciences, Inc. | 2.82% |
| 19 | IBRX | ImmunityBio, Inc. | 2.70% |
| 20 | CAI | Caris Life Sciences, Inc. | 2.16% |
| 21 | TYO: 4528 | Ono Pharmaceutical Co., Ltd. | 2.11% |
| 22 | RCUS | Arcus Biosciences, Inc. | 1.68% |
| 23 | CRSP | CRISPR Therapeutics AG | 1.57% |
| 24 | NVAX | Novavax, Inc. | 1.39% |
| 25 | IOVA | Iovance Biotherapeutics, Inc. | 1.29% |
As of Mar 27, 2026